VCM
HGEN

Versant Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Versant Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$2K – 1651
2021
Q2 		$2K Buy
+100
New +$1.82K ﹤0.01% 1203

Other funds holding HGEN

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Versant Capital Management's HGEN Position: Q3 2021 in Review

Versant Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q3 2021, closing a stake of 100 shares — an estimated $2K sold.

Versant Capital Management first reported a position in HGEN in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 85 funds tracked by Wall St. Rank hold HGEN as of Q3 2021.

  • Versant Capital Management reported no remaining HUMANIGEN, INC. position as of Q3 2021 after selling out during the quarter.
  • Versant Capital Management sold 100 HUMANIGEN, INC. shares in Q3 2021, an estimated $2K.
  • Versant Capital Management first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 1 quarter.
  • Versant Capital Management's HUMANIGEN, INC. position peaked at $2K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2021.

Based on Versant Capital Management's 13F filing for Q3 2021, filed 29 Oct 2021.